Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Neurobiology of substance P and the NK1 receptor.

Mantyh PW.

J Clin Psychiatry. 2002;63 Suppl 11:6-10. Review.

2.

Mutagenesis and knockout models: NK1 and substance P.

Bilkei-Gorzo A, Zimmer A.

Handb Exp Pharmacol. 2005;(169):143-62.

PMID:
16594257
3.

Clinical experience with substance P receptor (NK1) antagonists in depression.

Ranga K, Krishnan R.

J Clin Psychiatry. 2002;63 Suppl 11:25-9.

4.

Relationship between capsaicin-evoked substance P release and neurokinin 1 receptor internalization in the rat spinal cord.

Marvizón JC, Wang X, Matsuka Y, Neubert JK, Spigelman I.

Neuroscience. 2003;118(2):535-45.

PMID:
12699788
5.

Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?

Adell A.

Curr Drug Targets CNS Neurol Disord. 2004 Apr;3(2):113-21. Review. Erratum in: Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3)269.

PMID:
15078186
6.

Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1).

Santarelli L, Gobbi G, Blier P, Hen R.

J Clin Psychiatry. 2002;63 Suppl 11:11-7. Review.

7.

The tachykinin NK1 receptor in the brain: pharmacology and putative functions.

Saria A.

Eur J Pharmacol. 1999 Jun 30;375(1-3):51-60. Review.

PMID:
10443564
9.

Characteristics of substance P transport across the blood-brain barrier.

Chappa AK, Audus KL, Lunte SM.

Pharm Res. 2006 Jun;23(6):1201-8.

PMID:
16729222
10.
11.
12.

Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.

Duffy RA, Hedrick JA, Randolph G, Morgan CA, Cohen-Williams ME, Vassileva G, Lachowicz JE, Laverty M, Maguire M, Shan LS, Gustafson E, Varty GB.

Neuropharmacology. 2003 Aug;45(2):242-50.

PMID:
12842130
13.

Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor.

Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, Daughters RS, Lappi DA, Wiley RG, Simone DA.

Science. 1997 Oct 10;278(5336):275-9.

14.
15.

The role of substance P in stress and anxiety responses.

Ebner K, Singewald N.

Amino Acids. 2006 Oct;31(3):251-72. Review.

PMID:
16820980
16.

Neurokinin 1 receptor distribution in cholinergic neurons and targets of substance P terminals in the rat nucleus accumbens.

Pickel VM, Douglas J, Chan J, Gamp PD, Bunnett NW.

J Comp Neurol. 2000 Jul 31;423(3):500-11.

PMID:
10870089
17.

Calcitonin gene-related peptide regulates expression of neurokinin1 receptors by rat spinal neurons.

Seybold VS, McCarson KE, Mermelstein PG, Groth RD, Abrahams LG.

J Neurosci. 2003 Mar 1;23(5):1816-24.

18.
19.

Elimination of rat spinal substance P receptor bearing neurons dissociates cardiovascular and nocifensive responses to nicotinic agonists.

Khan IM, Wart CV, Singletary EA, Stanislaus S, Deerinck T, Yaksh TL, Printz MP.

Neuropharmacology. 2008 Feb;54(2):269-79.

20.
Items per page

Supplemental Content

Support Center